Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

计划入组 9,261 人 · 首次发布于 2021 年 11 月 8 日

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

计划入组 369,600 人 · 首次发布于 2021 年 12 月 7 日

A Real-world Study of Disease-modifying Therapy Treatment Outcomes in Patients With Spinal Muscular Atrophy

计划入组 4,805 人 · 首次发布于 2026 年 2 月 11 日

TSUCHIURA KYODO GENERAL HOSPITAL

Japan

MITO KYODO GENERAL HOSPITAL

Japan

OKEHAZAMA HOSPITAL FUJITA KOKORO CARE CENTER

Japan

Komodo Health's Real-World Evidence Platform Powers 31 Research Studies at ISPOR 2025

Strategic Collaborations and Novel Therapies Advance Cancer and Brain Injury Treatment

Real-World Study Challenges Traditional View of Thyroid Eye Disease Progression